As CD43 has been shown to favor cell proliferation of colon derived tumor cells, we assessed whether CD43 would provide an advantage to the tumor cell line DLD-1, a cell line derived from a stage 3 colorectal cancer. This evidence concerns the gene SPN and neoplasm.